Close Menu

NEW YORK (GenomeWeb) — Co-Diagnostics announced today that it has received CE-IVD marking for its Logix Smart ZDC multiplex test for the diagnosis of Zika virus, dengue fever, and chikungunya infection.

The PCR-based test is designed to identify and differentiate between Zika, all four serotypes of dengue, and chikungunya in serum samples, even in the presence of more than one target. It is available for purchase through Salt Lake City, Utah-based Co-Diagnostics' ISO 13485-certified facility.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
23

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.